← Open Payments lookup

JACK FACUNDUS: Open Payments

NPI 1376092809 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,256 in 11 payments from 10 companies in 2025. Trend: 2023 $564 · 2024 $1,265 · 2025 $1,256

Food & beverage: $1,256
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$242
Medtronic, Inc.1$146
Gilead Sciences, Inc.1$130
Neurocrine BioSciences, Inc.1$125
Amgen Inc.1$117
AstraZeneca Pharmaceuticals LP1$117
E.R. Squibb & Sons, L.L.C.1$114
Teva Pharmaceuticals USA, Inc.1$100
ABIOMED1$96
GENZYME CORPORATION1$68

Products named: CAPLYTA, SYMPLICITY G3, Livdelzi, INGREZZA, REPATHA, AIRSUPRA, COBENFY, FABRAZYME.

Industry payments across FL — which companies pay providers there.